Liver Metastases

Chapter 53


Liver Metastases




Summary of Key Points





Management of Colorectal Liver Metastases




• Improvements in surgical technique and perioperative management have allowed for safer hepatic resections.


• Hepatic resection is the first-line treatment of liver metastases, with 5-year survival rates between 25% and 58%.


• Survival after resection of liver metastases is influenced by the following risk factors: node-positive primary cancer, disease-free interval, tumor number, tumor size, number of metastases, and preoperative carcinoembryonic antigen level.


• Preoperative systemic therapy, although helpful in identifying patients most likely to benefit from resection of liver metastases, is associated with hepatotoxicity and may affect postresection hepatic regeneration.


• Fluorouracil, oxaliplatin, and irinotecan-based perioperative chemotherapy regimens are most commonly used in the adjunctive treatment of liver metastases.


• In approximately 20% of patients with initially unresectable liver metastases, the metastases may become resectable after administration of neoadjuvant chemotherapy.


• Portal vein embolization and the two-staged hepatectomy are also strategies for improving the resectability of initially unresectable liver metastases.


• Unresectable liver metastases can be managed with systemic therapy and/or a variety of liver-directed techniques such as radiofrequency ablation, microwave ablation, cryotherapy, hepatic artery infusion, or yttrium-90 radioembolization.

Stay updated, free articles. Join our Telegram channel

Jun 13, 2016 | Posted by in ONCOLOGY | Comments Off on Liver Metastases

Full access? Get Clinical Tree

Get Clinical Tree app for offline access